CooperSurgical Inc has signed an agreement to acquire Teva Pharmaceutical Industries Ltd's PARAGARD (intrauterine copper contraceptive) for $1.1bn in cash.
The deal will enable CooperSurgical to repay term loan debt and reinforce its central nervous system (CNS) in addition to its respiratory business areas.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
CooperSurgical is a medical and surgical products provider based in the US, while Teva is an Israeli pharmaceutical company.
Chinese firm Basecare Medical Device Co Ltd has secured CNY100m ($15.34m) in a series B funding round.
The company plans to use the funds towards the development of third-generation test-tube baby technology.
SPR Therapeutics LLC has secured $25m in a series C venture funding round led by a family office and Frontcourt Ventures.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe US-based company plans to use the funds towards the commercialisation of its FDA-cleared SPRINT peripheral nerve stimulation (PNS) system and additional research.
Cheetah Medical Inc has secured an additional $11.76m in a series C funding round, bringing the total funding to $40.61m. The company previously raised $14.4m in an extended series C financing round in February.
The US-based firm intends to use the stocks towards the expansion of its business in the country.
